Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triamcinolone Levels in Cochlear Perilymph

NCT03248856 is registered in ClinicalTrials.gov with Christoph Arnoldner as lead sponsor.

NCT NCT03248856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03248856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triamcinolone Levels in Cochlear Perilymph
Lead sponsor
Christoph Arnoldner
Phase
Phase 1
Overall status
Completed
Start date
October 2, 2017
Completion date
May 31, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cochlear hearing loss